{
    "organizations": [],
    "uuid": "cc06b90b8f2ca4efd9ede60b63910fc4754badb7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/wilson-therapeut-ma-alexion-pharms/alexion-to-buy-swedish-biotech-wilson-therapeutics-for-855-mln-idUSL8N1RO12E",
    "ord_in_thread": 0,
    "title": "Alexion to buy Swedish biotech Wilson Therapeutics for $855 mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11 (Reuters) - Alexion Pharmaceuticals said on Wednesday it had agreed to buy Swedenâ€™s Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million) to boost its line-up of rare disease drugs.\nThe U.S. group is acquiring the business through a tender offer worth 232 crowns per share.\n$1 = 8.3000 Swedish crowns Reporting by Ben Hirschler; Editing by Susan Fenton\n ",
    "published": "2018-04-11T14:33:00.000+03:00",
    "crawled": "2018-04-12T14:13:48.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "alexion",
        "pharmaceutical",
        "said",
        "wednesday",
        "agreed",
        "buy",
        "sweden",
        "wilson",
        "therapeutic",
        "billion",
        "swedish",
        "crown",
        "million",
        "boost",
        "rare",
        "disease",
        "drug",
        "group",
        "acquiring",
        "business",
        "tender",
        "offer",
        "worth",
        "crown",
        "per",
        "share",
        "swedish",
        "crown",
        "reporting",
        "ben",
        "hirschler",
        "editing",
        "susan",
        "fenton"
    ]
}